Abstract
In 2007, the US market for nonvascular interventional radiology devices was
valued at nearly $120 million.
This market is comprised of radiofrequency ablation devices for cancer
treatment, percutaneous drainage catheters, and soft-tissue biopsy needles.
View Cart
